CROCS INC (CROX) Fundamental Analysis & Valuation

NASDAQ:CROX • US2270461096

83.57 USD
-1.81 (-2.12%)
At close: Mar 4, 2026
83.22 USD
-0.35 (-0.42%)
Pre-Market: 3/5/2026, 8:29:10 AM

This CROX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CROX. CROX was compared to 45 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and the financial health of CROX get a neutral evaluation. Nothing too spectacular is happening here. CROX is valued quite cheap, while showing a decent growth score. This is a good combination! This makes CROX very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. CROX Profitability Analysis

1.1 Basic Checks

  • In the past year CROX was profitable.
  • In the past year CROX had a positive cash flow from operations.
  • Of the past 5 years CROX 4 years were profitable.
  • Each year in the past 5 years CROX had a positive operating cash flow.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B

1.2 Ratios

  • CROX has a Return On Assets of -1.94%. This is in the lower half of the industry: CROX underperforms 64.44% of its industry peers.
  • CROX has a Return On Equity of -6.28%. This is in the lower half of the industry: CROX underperforms 66.67% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 20.18%, CROX belongs to the top of the industry, outperforming 91.11% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 11.67%.
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROIC 20.18%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K 5K

1.3 Margins

  • CROX has a better Operating Margin (21.97%) than 93.33% of its industry peers.
  • CROX's Operating Margin has improved in the last couple of years.
  • CROX's Gross Margin of 58.33% is fine compared to the rest of the industry. CROX outperforms 73.33% of its industry peers.
  • In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 21.97%
PM (TTM) N/A
GM 58.33%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

5

2. CROX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
  • Compared to 1 year ago, CROX has less shares outstanding
  • CROX has less shares outstanding than it did 5 years ago.
  • CROX has a worse debt/assets ratio than last year.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 3.79 indicates that CROX is not in any danger for bankruptcy at the moment.
  • CROX has a better Altman-Z score (3.79) than 77.78% of its industry peers.
  • The Debt to FCF ratio of CROX is 1.87, which is an excellent value as it means it would take CROX, only 1.87 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 1.87, CROX is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • CROX has a Debt/Equity ratio of 0.95. This is a neutral value indicating CROX is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.95, CROX is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
  • Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Altman-Z 3.79
ROIC/WACC1.89
WACC10.67%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that CROX should not have too much problems paying its short term obligations.
  • CROX's Current ratio of 1.27 is on the low side compared to the rest of the industry. CROX is outperformed by 86.67% of its industry peers.
  • A Quick Ratio of 0.74 indicates that CROX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.74, CROX is not doing good in the industry: 84.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.74
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. CROX Growth Analysis

3.1 Past

  • The earnings per share for CROX have decreased by -5.40% in the last year.
  • Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.96% on average per year.
  • CROX shows a decrease in Revenue. In the last year, the revenue decreased by -1.50%.
  • CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.86% yearly.
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.01% on average over the next years.
  • CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.35% yearly.
EPS Next Y-2.04%
EPS Next 2Y0.19%
EPS Next 3Y5.3%
EPS Next 5Y5.01%
Revenue Next Year0.69%
Revenue Next 2Y1.58%
Revenue Next 3Y1.5%
Revenue Next 5Y3.35%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. CROX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.72, the valuation of CROX can be described as very cheap.
  • Based on the Price/Earnings ratio, CROX is valued cheaper than 95.56% of the companies in the same industry.
  • CROX is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 6.86, which indicates a rather cheap valuation of CROX.
  • Based on the Price/Forward Earnings ratio, CROX is valued cheaply inside the industry as 95.56% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of CROX to the average of the S&P500 Index (25.11), we can say CROX is valued rather cheaply.
Industry RankSector Rank
PE 6.72
Fwd PE 6.86
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 88.89% of the companies in the same industry are more expensive than CROX, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CROX is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.58
EV/EBITDA 5.63
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The decent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.22
EPS Next 2Y0.19%
EPS Next 3Y5.3%

0

5. CROX Dividend Analysis

5.1 Amount

  • CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CROX Fundamentals: All Metrics, Ratios and Statistics

CROCS INC

NASDAQ:CROX (3/4/2026, 8:17:33 PM)

Premarket: 83.22 -0.35 (-0.42%)

83.57

-1.81 (-2.12%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners99.37%
Inst Owner Change-3.08%
Ins Owners2.89%
Ins Owner Change0.54%
Market Cap4.34B
Revenue(TTM)4.04B
Net Income(TTM)-81.20M
Analysts72.73
Price Target104.76 (25.36%)
Short Float %10.85%
Short Ratio4.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.66%
Min EPS beat(2)18.22%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)15.32%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)15.96%
EPS beat(12)12
Avg EPS beat(12)14.53%
EPS beat(16)16
Avg EPS beat(16)15.58%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)1.48%
Max Revenue beat(2)1.79%
Revenue beat(4)3
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.79%
Revenue beat(8)5
Avg Revenue beat(8)0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.54%
Revenue beat(16)10
Avg Revenue beat(16)0.77%
PT rev (1m)12.66%
PT rev (3m)12.18%
EPS NQ rev (1m)8.55%
EPS NQ rev (3m)9.38%
EPS NY rev (1m)-0.42%
EPS NY rev (3m)0.27%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)1.31%
Revenue NY rev (3m)1.06%
Valuation
Industry RankSector Rank
PE 6.72
Fwd PE 6.86
P/S 1.07
P/FCF 6.58
P/OCF 6.11
P/B 3.35
P/tB N/A
EV/EBITDA 5.63
EPS(TTM)12.44
EY14.89%
EPS(NY)12.19
Fwd EY14.58%
FCF(TTM)12.7
FCFY15.19%
OCF(TTM)13.68
OCFY16.37%
SpS77.82
BVpS24.91
TBVpS-8.4
PEG (NY)N/A
PEG (5Y)0.22
Graham Number83.5
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROCE 25.55%
ROIC 20.18%
ROICexc 20.97%
ROICexgc 43.42%
OM 21.97%
PM (TTM) N/A
GM 58.33%
FCFM 16.31%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
ROICexc(3y)21.34%
ROICexc(5y)28.15%
ROICexgc(3y)55.47%
ROICexgc(5y)57.23%
ROCE(3y)25.94%
ROCE(5y)32.05%
ROICexgc growth 3Y-10.15%
ROICexgc growth 5Y7.53%
ROICexc growth 3Y3.65%
ROICexc growth 5Y-5.95%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Debt/EBITDA 1.27
Cap/Depr 64.62%
Cap/Sales 1.27%
Interest Coverage 11.43
Cash Conversion 73.47%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.74
Altman-Z 3.79
F-Score5
WACC10.67%
ROIC/WACC1.89
Cap/Depr(3y)125.61%
Cap/Depr(5y)1207.8%
Cap/Sales(3y)1.96%
Cap/Sales(5y)13.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
EPS Next Y-2.04%
EPS Next 2Y0.19%
EPS Next 3Y5.3%
EPS Next 5Y5.01%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%
Revenue Next Year0.69%
Revenue Next 2Y1.58%
Revenue Next 3Y1.5%
Revenue Next 5Y3.35%
EBIT growth 1Y-15.14%
EBIT growth 3Y0.5%
EBIT growth 5Y28.92%
EBIT Next Year10.94%
EBIT Next 3Y2.54%
EBIT Next 5Y8.54%
FCF growth 1Y-28.59%
FCF growth 3YN/A
FCF growth 5Y24%
OCF growth 1Y-28.42%
OCF growth 3Y5.61%
OCF growth 5Y21.63%

CROCS INC / CROX FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CROX.


Can you provide the valuation status for CROCS INC?

ChartMill assigns a valuation rating of 8 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


What is the profitability of CROX stock?

CROCS INC (CROX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CROCS INC?

The Earnings per Share (EPS) of CROCS INC (CROX) is expected to decline by -2.04% in the next year.


Is the dividend of CROCS INC sustainable?

The dividend rating of CROCS INC (CROX) is 0 / 10 and the dividend payout ratio is 0%.